Not logged in.png)
Share.png)
SaveShare Save Performance status improvement and advances in systemic treatment after brain metastases resection: a retrospective single-center cohort study of non-small cell lung cancer patients
Hosoya, Kazutaka; Ozasa, Hiroaki; Tanji, Masahiro; Yoshida, Hiroshi; Ajimizu, Hitomi; Tsuji, Takahiro; Yoshida, Hironori; Terada, Yukinori; Sano, Noritaka; Mineharu, Yohei; Miyamoto, Susumu; Hirai, Toyohiro; Arakawa, Yoshiki Share Save Establishment of intratumor heterogeneity using patient derived lung cancer cellsFunazo, Tomoko; Ozasa, Hiroaki; Tsuji, Takahiro; Shima, Yusuke; Suminaga, Keiichiro; Hashimoto, Kentaro; Yoshida, Hiroshi; Ogimoto, Tatsuya; Hosoya, Kazutaka; Ajimizu, Hitomi; Nomizo, Takashi; Yoshida, Hironori; Hirai, Toyohiro Share Save Share Save Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in EGFR Mutation-positive Lung CancerOgimoto, Tatsuya; Ozasa, Hiroaki; Tsuji, Takahiro; Funazo, Tomoko; Yamazoe, Masatoshi; Hashimoto, Kentaro; Yoshida, Hiroshi; Hosoya, Kazutaka; Ajimizu, Hitomi; Nomizo, Takashi; Yoshida, Hironori; Hamaji, Masatsugu; Menju, Toshi; Yoshizawa, Akihiko; Date, Hiroshi; Hirai, Toyohiro Share Save Share Save Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer (Dec, 10.1038/s41598-021-03139-5, 2021)Ajimizu, Hitomi; Ozasa, Hiroaki; Sato, Susumu; Funazo, Tomoko; Sakamori, Yuichi; Nomizo, Takashi; Kuninaga, Kiyomitsu; Ogimoto, Tatsuya; Hosoya, Kazutaka; Yamazoe, Masatoshi; Tsuji, Takahiro; Yoshida, Hironori; Itotani, Ryo; Ueno, Kentaro; Kim, Young Hak; Muro, Shigeo; Hirai, Toyohiro Share Save Adaptive resistance to lorlatinib via EGFR signaling in ALK-rearranged lung cancerKatayama, Yuki; Yamada, Tadaaki; Tanimura, Keiko; Tokuda, Shinsaku; Morimoto, Kenji; Hirai, Soichi; Matsui, Yohei; Nakamura, Ryota; Ishida, Masaki; Kawachi, Hayato; Yoneda, Kazue; Hosoya, Kazutaka; Tsuji, Takahiro; Ozasa, Hiroaki; Yoshimura, Akihiro; Iwasaku, Masahiro; Kim, Young Hak; Horinaka, Mano; Sakai, Toshiyuki; Utsumi, Takahiro; Shiotsu, Shinsuke; Takeda, Takayuki; Katayama, Ryohei; Takayama, Koichi Share Save Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancerAjimizu, Hitomi; Ozasa, Hiroaki; Sato, Susumu; Funazo, Tomoko; Sakamori, Yuichi; Nomizo, Takashi; Kuninaga, Kiyomitsu; Ogimoto, Tatsuya; Hosoya, Kazutaka; Yamazoe, Masatoshi; Tsuji, Takahiro; Yoshida, Hironori; Itotani, Ryo; Ueno, Kentaro; Kim, Young Hak; Muro, Shigeo; Hirai, Toyohiro Share Save Share Save Share Save PD-L1 polymorphisms predict survival outcomes in advanced non-small-cell lung cancer patients treated with PD-1 blockadeYoshida, Hironori; Nomizo, Takashi; Ozasa, Hiroaki; Tsuji, Takahiro; Funazo, Tomoko; Yasuda, Yuto; Ajimizu, Hitomi; Yamazoe, Masatoshi; Kuninaga, Kiyomitsu; Ogimoto, Tatsuya; Hosoya, Kazutaka; Itotani, Ryo; Sakamori, Yuichi; Kim, Young Hak; Hirai, Toyohiro Share Save Acquired Resistance to Alectinib in ALK-Rearranged Lung Cancer due to ABCC11/MRP8 Overexpression in a Clinically Paired Resistance ModelFunazo, Tomoko; Tsuji, Takahiro; Ozasa, Hiroaki; Furugaki, Koh; Yoshimura, Yasushi; Oguri, Tetsuya; Ajimizu, Hitomi; Yasuda, Yuto; Nomizo, Takashi; Sakamori, Yuichi; Yoshida, Hironori; Kim, Young Hak; Hirai, Toyohiro Share Save MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-XL expressionYasuda, Yuto; Ozasa, Hiroaki; Kim, Young Hak; Yamazoe, Masatoshi; Ajimizu, Hitomi; Funazo, Tomoko Yamamoto; Nomizo, Takashi; Tsuji, Takahiro; Yoshida, Hironori; Sakamori, Yuichi; Nakajima, Naoki; Menju, Toshi; Yoshizawa, Akihiko; Date, Hiroshi; Hirai, Toyohiro Share Save YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulationTsuji, Takahiro; Ozasa, Hiroaki; Aoki, Wataru; Aburaya, Shunsuke; Funazo, Tomoko Yamamoto; Furugaki, Koh; Yoshimura, Yasushi; Yamazoe, Masatoshi; Ajimizu, Hitomi; Yasuda, Yuto; Nomizo, Takashi; Yoshida, Hironori; Sakamori, Yuichi; Wake, Hiroaki; Ueda, Mitsuyoshi; Kim, Young Hak; Hirai, Toyohiro Share Save Share Save Clinical impact of low serum free T4 in patients with non-small cell lung cancer treated with nivolumabFunazo, Tomoko Yamamoto; Nomizo, Takashi; Ozasa, Hiroaki; Tsuji, Takahiro; Yasuda, Yuto; Yoshida, Hironori; Sakamori, Yuichi; Nagai, Hiroki; Hirai, Toyohiro; Kim, Young Hak Share Save ABCC11 is involved in resistance to alectinibFunazo, Tomoko Yamamoto; Ozasa, Hiroaki; Tsuji, Takahiro; Furugaki, Koh; Yoshimura, Yasushi; Ajimizu, Hitomi; Yasuda, Yuto; Nomizo, Takashi; Sakamori, Yuichi; Yoshida, Hironori; Kim, Young Hak; Hirai, Toyohiro Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}